Cases of COVID-19 in Those With Epilepsy Low Early in the Pandemic

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 19, 2024.

By Lori Solomon HealthDay Reporter

THURSDAY, Sept. 19, 2024 -- On a global scale, people with epilepsy reported low rates of COVID-19 early in the pandemic, according to a study published online Sept. 3 in Epilepsia Open.

Michael J. Vasey, from the East London NHS Foundation Trust in Bedford, United Kingdom, and colleagues conducted separate surveys of people with epilepsy (2,105 from 53 countries) and health care workers (HCWs; 392 from 26 countries; April 2020 to September 2021) to understand COVID-19 infections, the effect of COVID-19-related restrictions, access to specialist help for epilepsy (people with epilepsy), and the impact of the pandemic on work productivity (HCWs).

The researchers found that the same proportion of people with epilepsy in high-income countries (HICs) and non-HICs reported COVID-19 infection (7 percent). Participants in HICs were significantly more likely to report that COVID-19 measures had affected their health (32 versus 23 percent). There were no differences in the proportion of those who reported difficulty in obtaining help for epilepsy among those living in non-HICs and HICs. Compared with HCWs in HICs, HCWs in non-HICs were significantly more likely to report COVID-19 infection than those in HICs (6 versus 18 percent). Further, HCWs in non-HICs reported their clinical work had been affected by concerns about contracting COVID-19, lack of personal protective equipment, and the impact of the pandemic on mental health. The pandemic was tied to a significant shift to remote consultations in both non-HICs and HICs.

"Planning for future pandemics should prioritize mental health care alongside ensuring access to essential epilepsy services and expanding and enhancing access to remote consultations," the authors write.

Several authors disclosed ties to relevant organizations.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-09-20 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords